New pill could help kidney patients fight anemia without needles
NCT ID NCT03402386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called MT-6548 in 42 people in Japan who have anemia due to chronic kidney disease and are on peritoneal dialysis. The goal was to see if the drug can safely raise and maintain healthy red blood cell levels. Participants either switched from another anemia treatment or started the drug fresh.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research site
Aichi, Japan
-
Research site
Chiba, Japan
-
Research site
Fukuoka, Japan
-
Research site
Fukushima, Japan
-
Research site
Gunma, Japan
-
Research site
Hokkaido, Japan
-
Research site
Hyōgo, Japan
-
Research site
Ibaraki, Japan
-
Research site
Kagoshima, Japan
-
Research site
Kanagawa, Japan
-
Research site
Kyoto, Japan
-
Research site
Nagano, Japan
-
Research site
Nara, Japan
-
Research site
Okayama, Japan
-
Research site
Okinawa, Japan
-
Research site
Shiga, Japan
-
Research site
Tokyo, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A pill vs. a shot: which eases Kidney-Related anemia better?
- Can a pill replace EPO shots for anemia in kidney disease?
- New oral drug could replace injections for kidney anemia
- New pill could help dialysis patients fight anemia without needles
- New pill could replace needles for anemia in dialysis patients
- New anemia pill challenges standard shot for dialysis patients